207 related articles for article (PubMed ID: 9669733)
21. Fluticasone propionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescents.
LaForce CF; Dockhorn RJ; Findlay SR; Meltzer EO; Nathan RA; Stricker W; Weakley S; Field EA; Rogenes PR
J Fam Pract; 1994 Feb; 38(2):145-52. PubMed ID: 8308505
[TBL] [Abstract][Full Text] [Related]
22. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility.
Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
Lung; 2006; 184(4):217-22. PubMed ID: 17006748
[TBL] [Abstract][Full Text] [Related]
23. [Inhaled corticosteroids: first-line therapy in asthma].
Hajiro T; Ishihara K
Nihon Rinsho; 2001 Oct; 59(10):1967-72. PubMed ID: 11676140
[TBL] [Abstract][Full Text] [Related]
24. Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis.
Peterson KA; Thomas KL; Hilden K; Emerson LL; Wills JC; Fang JC
Dig Dis Sci; 2010 May; 55(5):1313-9. PubMed ID: 19533356
[TBL] [Abstract][Full Text] [Related]
25. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate.
Teitelbaum JE; Fox VL; Twarog FJ; Nurko S; Antonioli D; Gleich G; Badizadegan K; Furuta GT
Gastroenterology; 2002 May; 122(5):1216-25. PubMed ID: 11984507
[TBL] [Abstract][Full Text] [Related]
26. Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis.
Balfour-Lynn IM; Lees B; Hall P; Phillips G; Khan M; Flather M; Elborn JS;
Am J Respir Crit Care Med; 2006 Jun; 173(12):1356-62. PubMed ID: 16556691
[TBL] [Abstract][Full Text] [Related]
27. Inhaled corticosteroids and adrenal insufficiency.
Russell G
Arch Dis Child; 2002 Dec; 87(6):455-6. PubMed ID: 12456537
[TBL] [Abstract][Full Text] [Related]
28. Reducing inhaled corticosteroids in asthma is just the start.
Weiner JM
Med J Aust; 2003 Aug; 179(3):173. PubMed ID: 12885275
[No Abstract] [Full Text] [Related]
29. Eosinophilic esophagitis.
Shitrit AB; Reinus C; Zeides S; Braverman D
Isr Med Assoc J; 2006 Aug; 8(8):587. PubMed ID: 16958256
[No Abstract] [Full Text] [Related]
30. [Locally acting corticosteroids in inflammatory bowel disease. Are they effective? Are they really less toxic?].
Nos Mateu P
Gastroenterol Hepatol; 2008 Sep; 31 Suppl 3():16-21. PubMed ID: 19087859
[No Abstract] [Full Text] [Related]
31. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
Gustafsson P; Tsanakas J; Gold M; Primhak R; Radford M; Gillies E
Arch Dis Child; 1993 Aug; 69(2):206-11. PubMed ID: 8215522
[TBL] [Abstract][Full Text] [Related]
32. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ; Currie GP; Lipworth BJ
J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
[TBL] [Abstract][Full Text] [Related]
33. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
Peden DB; Berger WE; Noonan MJ; Thomas MR; Hendricks VL; Hamedani AG; Mahajan P; House KW
J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
[TBL] [Abstract][Full Text] [Related]
34. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
Postma DS; Roche N; Colice G; Israel E; Martin RJ; van Aalderen WM; Grigg J; Burden A; Hillyer EV; von Ziegenweidt J; Gopalan G; Price D
Int J Chron Obstruct Pulmon Dis; 2014; 9():1163-86. PubMed ID: 25378918
[TBL] [Abstract][Full Text] [Related]
35. Inhaled steroids in COPD.
Barnes NC
Lancet; 1998 Mar; 351(9105):766-7. PubMed ID: 9519941
[No Abstract] [Full Text] [Related]
36. Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis.
Kuchen T; Straumann A; Safroneeva E; Romero Y; Bussmann C; Vavricka S; Netzer P; Reinhard A; Portmann S; Schoepfer AM
Allergy; 2014 Sep; 69(9):1248-54. PubMed ID: 24894658
[TBL] [Abstract][Full Text] [Related]
37. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis.
Konikoff MR; Noel RJ; Blanchard C; Kirby C; Jameson SC; Buckmeier BK; Akers R; Cohen MB; Collins MH; Assa'ad AH; Aceves SS; Putnam PE; Rothenberg ME
Gastroenterology; 2006 Nov; 131(5):1381-91. PubMed ID: 17101314
[TBL] [Abstract][Full Text] [Related]
38. Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis.
Sayej WN; Patel R; Baker RD; Tron E; Baker SS
J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):393-9. PubMed ID: 19633574
[TBL] [Abstract][Full Text] [Related]
39. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
40. Adrenal insufficiency after treatment with fluticasone. Lowest possible dose of inhaled glucocorticoids should be given.
Patel L; Clayton PE
BMJ; 2002 Oct; 325(7368):836; author reply 836. PubMed ID: 12378733
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
